The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Insulin resistance is a cardiovascular risk factor in humans
Abstract
Diabetes is a common metabolic disorder associated to elevated cardiovascular morbidity and mortality that is not explained by hyperglycemia or traditional cardiovascular risk factors such as smoking or hypercholesterolemia. Intensive glycemic control with insulin that achieves near-normal glycemia does not reduce significantly macrovascular complications compared with conventional glycemic control. Cardiovascular disease continues to develop in patients with diabetes despite adequate glycemic control. In contrast, intensive control with metformin (leading to insulin resistance improvement) reduces diabetes complications, including cardiovascular events, suggesting that enhancement of insulin sensitivity rather than plasma glucose level has a major role improving diabetes outcomes. Accordingly, insulin resistance estimated by glucose tolerance tests is better predictor of future cardiovascular events than fasting glucose level in nondiabetic individuals. Insulin resistance precedes for decades the clinical onset of type 2 diabetes and deteriorates metabolic control of type 1 diabetes. Numerous investigations including cross-sectional and prospective studies, meta-analyses, and systematic reviews provide compelling evidence that insulin resistance by itself is a cardiovascular risk factor in a variety of population groups, including the general population and patients with diabetes. Several estimations of insulin resistance have been consistently associated with elevated rate of cardiovascular events independently of other cardiovascular risk factors and diabetes status. The clinical expression of insulin resistance (the metabolic syndrome or any of its components including obesity, hyperinsulinemia, hypertension, and dyslipemia) has been related to cardiovascular disease as well. An estimation conducted by the Archimedes model confirms that insulin resistance is the most important single cause of coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & Stern, M. P. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,238
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
(1970) · PubMed · Cited by 976
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., & Cornu, C. (2011) · BMJ · doi:10.1136/bmj.d4169 · Cited by 803
Ninomiya, J. K., L’Italien, G., Criqui, M. H., Whyte, J. L., Gamst, A., & Chen, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000108926.04022.0c · Cited by 793
Welborn, T. A., & Wearne, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.154 · Cited by 735
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
Fuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J., & Keen, H. (1983) · BMJ · doi:10.1136/bmj.287.6396.867 · Cited by 633
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 632
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
Sattar, N., McConnachie, A., Shaper, A. G., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., Jukema, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60602-9 · Cited by 493
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492
Pre-Diabetes and the Risk for Cardiovascular Disease
Ford, E. S., Zhao, G., & Li, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.060 · Cited by 480
Haffner, S. M., Mykkänen, L., Festa, A., Burke, J. P., & Stern, M. P. (2000) · Circulation · doi:10.1161/01.cir.101.9.975 · Cited by 457
Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1982 · Cited by 439
Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052036 · Cited by 403
Steele, A. M., Shields, B. M., Wensley, K. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · JAMA · doi:10.1001/jama.2013.283980 · Cited by 381
Fontbonne, A., Charles, M. A., Thibult, N., Richard, J. L., Claude, J. R., Warnet, J. M., Rosselin, G. E., & Eschw�ge, E. (1991) · Diabetologia · doi:10.1007/bf00405009 · Cited by 377
Sundström, J., Risérus, U., Byberg, L., Zethelius, B., Lithell, H., & Lind, L. (2006) · BMJ · doi:10.1136/bmj.38766.624097.1f · Cited by 375
Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
Yip, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2773 · Cited by 360
Pyörälä, M., Miettinen, H., Laakso, M., & Pyörälä, K. (1998) · Circulation · doi:10.1161/01.cir.98.5.398 · Cited by 349
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3252 · Cited by 307
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease
Jeppesen, J., Hansen, T. W., Rasmussen, S., Ibsen, H., Torp-Pedersen, C., & Madsbad, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.088 · Cited by 286
Nathan, D. M., Bayless, M., Cleary, P., Genuth, S., Gubitosi-Klug, R., Lachin, J. M., Lorenzi, G., Zinman, B., & for the DCCT/EDIC Research Group (2013) · Diabetes · doi:10.2337/db13-1093 · Cited by 272
Cleary, P. A., Orchard, T. J., Genuth, S., Wong, N. D., Detrano, R., Backlund, J.-Y. C., Zinman, B., Jacobson, A., Sun, W., Lachin, J. M., et al. (2006) · Diabetes · doi:10.2337/db06-0653 · Cited by 264
Abraira, C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.2.181 · Cited by 253
Dabelea, D., Kinney, G., Snell-Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S., Hamman, R. F., & Rewers, M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2833 · Cited by 250
Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011) · Diabetes · doi:10.2337/db10-0328 · Cited by 230
Mg, G. (1971) · JAMA · doi:10.1001/jama.218.9.1400 · Cited by 221
Hedblad, B., Nilsson, P., Engström, G., Berglund, G., & Janzon, L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00719.x · Cited by 203
Cardiovascular Disease and Its Risk Factors in IDDM in Europe
Koivisto, V. A., Stevens, I. K., Mattock, M., Ebeling, P., Muggeo, M., Stephenson, J., Idzior-Walus, B., & The EURODIAB IDDM Complications Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.7.689 · Cited by 198
Saely, C. H., Aczel, S., Marte, T., Langer, P., Hoefle, G., & Drexel, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0799 · Cited by 191
the Metascreen Writing Committee (2006) · Diabetes Care · doi:10.2337/dc06-0942 · Cited by 188
Sarwar, N., Aspelund, T., Eiriksdottir, G., Gobin, R., Seshasai, S. R. K., Forouhi, N. G., Sigurdsson, G., Danesh, J., & Gudnason, V. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000278 · Cited by 175
Eddy, D. M., Schlessinger, L., Kahn, R., Peskin, B., & SCHIEBINGER, R. J. (2008) · Diabetes Care · doi:10.2337/dc08-0854 · Cited by 169
Urbina, E. M., Wadwa, R. P., Davis, C., Snively, B. M., Dolan, L. M., Daniels, S. R., Hamman, R. F., & Dabelea, D. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.011 · Cited by 158
Progression of Coronary Artery Calcification in Type 1 Diabetes
Snell‐Bergeon, J. K., Hokanson, J. E., Jensen, L. E., MacKenzie, T. A., Kinney, G. L., Dabelea, D., Eckel, R. H., Ehrlich, J., Garg, S. K., & Rewers, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2923 · Cited by 146
Hyperinsulinaemia is not a major coronary risk factor in elderly men
Welin, L., Eriksson, H., Larsson, B., Ohlson, L. ‐., Svärdsudd, K., & Tibblin, G. (1992) · Diabetologia · doi:10.1007/bf00429098 · Cited by 138
Fröhlich-Reiterer, E. E., Rosenbauer, J., Pozza, S. B., Hofer, S. E., Schober, E., Holl, R. W., & on behalf of the DPV-Wiss Study Group and the German BMBF Competence Networks Diabetes mellitus and Obesity (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304237 · Cited by 128
Polak, J. F., Backlund, J. C., Cleary, P. A., Harrington, A. P., O’Leary, D. H., Lachin, J. M., & Nathan, D. M. (2011) · Diabetes · doi:10.2337/db10-0296 · Cited by 125
Tzagournis, M., Chiles, R. P., Ryan, J. M., et al. (1968) · Circulation · doi:10.1161/01.cir.38.6.1156 · Cited by 117
Zethelius, B., Lithell, H., Hales, C. N., & Berne, C. (2005) · Diabetologia · doi:10.1007/s00125-005-1711-9 · Cited by 111
Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell‐Bergeon, J. K., Eckel, R. H., Perreault, L., & Rewers, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3172 · Cited by 110
Rönnemaa, T., Laakso, M., Pyörälà, K., Kallio, V., & Puukka, P. J. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.80 · Cited by 109
Olson, J. C., Erbey, J. R., Forrest, K. Y. Z., Williams, K. V., Becker, D. J., & Orchard, T. J. (2002) · Metabolism · doi:10.1053/meta.2002.30021 · Cited by 105
van Vliet, M., van der Heyden, J. C., Diamant, M., von Rosenstiel, I. A., Schindhelm, R. K., Aanstoot, H., & Veeze, H. J. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.017 · Cited by 101
Tenenbaum, A., Adler, Y., Boyko, V., Tenenbaum, H., Fisman, E. Z., Tanné, D., Lapidot, M., Schwammenthal, E., Feinberg, M. S., Matas, Z., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.008 · Cited by 99
Olson, J., Erbey, J. R., Williams, K. V., Becker, D. J., Edmundowicz, D., Kelsey, S. F., Tyrrell, K. S., & Orchard, T. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00269-1 · Cited by 87
SHAH, A. S., Wadwa, R. P., Dabelea, D., Hamman, R. F., D'Agostino, R., Marcovina, S. M., Daniels, S. R., Dolan, L. M., Fino, N. F., & Urbina, E. M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12279 · Cited by 84
YARNELL, J. W. G., Sweetnam, P. M., Marks, V., Teale, J. D., & Bolton, C. (1994) · Heart · doi:10.1136/hrt.71.3.293 · Cited by 78
Eeg‐Olofsson, K., Guðbjörnsdóttir, S., Eliasson, B., Zethelius, B., & Cederholm, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.010 · Cited by 71
Zhang, X., Li, J., Zheng, S., Luo, Q., Zhou, C., & Wang, C. (2017) · Bioscience Reports · doi:10.1042/bsr20170947 · Cited by 64
Vaccaro, O., Ruth, K. J., & Stamler, J. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1328 · Cited by 56
Clinical Characteristics of Subjects with a Missense Mutation in Glucokinase
Page, R. C., Lévy, J., Barrow, B. A., Turner, R. C., Patel, P., Hattersley, A. T., Lo, D., Wainscoat, J. S., Permutt, M. A., & Bell, G. I. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00460.x · Cited by 55
GENUTH, S. M., Backlund, J. C., Bayless, M., Bluemke, D. A., Cleary, P. A., Crandall, J. P., Lachin, J. M., Lima, J. A. C., Miao, C., & Turkbey, E. B. (2013) · Diabetes · doi:10.2337/db12-0546 · Cited by 49
Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study
SHAH, A. S., Black, S., Wadwa, R. P., Schmiege, S. J., Fino, N. F., Talton, J. W., D’Agostino, R., Hamman, R. F., Urbina, E. M., Dolan, L. M., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.02.004 · Cited by 47
Insulin sensitivity and vascular disease in insulin-dependent diabetics.
Martin, F. I. R., & Stocks, A. E. (1968) · BMJ · doi:10.1136/bmj.2.5597.81 · Cited by 46
Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
Bacha, F. F., & Bartz, S. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12337 · Cited by 45
Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease
Inchiostro, S., Bertoli, G., Zanette, G., & Donadon, V. (1994) · Diabetologia · doi:10.1007/bf00403379 · Cited by 43
Yanase, M., Takatsu, F., Tagawa, T., Kato, T., Arai, K., Koyasu, M., Horibe, H., NOMOTO, S., Takemoto, K., Shimizu, S., et al. (2003) · Circulation Journal · doi:10.1253/circj.68.47 · Cited by 42
Martin, F. I. R., & Hopper, J. L. (1987) · Diabetologia · doi:10.1007/bf00274219 · Cited by 39
Johansen, N. B., Charles, M., Vistisen, D., Rasmussen, S. S., Wiinberg, N., Borch‐Johnsen, K., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0176 · Cited by 28
Fasting and Post-Challenge Glucose as Quantitative Cardiovascular Risk Factors: A Meta-Analysis
Kodama, S., Saito, K., Tanaka, S., Horikawa, C., Fujiwara, K., Hirasawa, R., Yachi, Y., Sone, Y., Iida, K., Shimano, H., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10975 · Cited by 24
Does Insulin Resistance Drive the Association between Hyperglycemia and Cardiovascular Risk?
Færch, K., Bergman, B. C., & Perreault, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039260 · Cited by 20
Ikezaki, H., Ai, M., Schaefer, E. J., Otokozawa, S., Asztalos, B. F., Nakajima, K., Zhou, Y., Liu, C., Jacques, P. F., Cupples, L. A., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.014 · Cited by 15
Out, M., Miedema, I., Jager‐Wittenaar, H., van der Schans, C. P., Krijnen, W. P., Lehert, P., Stehouwer, C. D. A., & Kooy, A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13054 · Cited by 12
Tan, C., Sasagawa, Y., & Mori, M. (2017) · Journal of General and Family Medicine · doi:10.1002/jgf2.94 · Cited by 9
Cited by
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
Lopez-Jaramillo, P., Gomez-Arbelaez, D., Martinez-Bello, D., Abat, M. E. M., Alhabib, K. F., Avezum, Á., Barbarash, O., Chifamba, J., Diaz, M. L., Gulec, S., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00247-1 · Cited by 386
Lopez-Jimenez, F., Almahmeed, W., Bays, H., Cuevas, A., Di Angelantonio, E., le Roux, C. W., Sattar, N., Sun, M. C., Wittert, G., Pinto, F. J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac187 · Cited by 362
Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home
Azelton, K. R., Crowley, A. P., Vence, N., Underwood, K., Morris, G., Kelly, J., & Landry, M. J. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.764735 · Cited by 49
Metadata
- Authors
- Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 13
- Issue
- 2
- Pages
- 1449-1455
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W2917667939
- Cited by
- 313
- References
- 94
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.